• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs Roche's Nasal Swab MRSA Test

    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

    Eye Test for Parkinson's Gains Breakthrough Designation

    Biomerics Forms New Business Unit

    J&J's New Monofocal IOL for Cataract Patients with Astigmatism
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Zeus

    FUTEK Advanced Sensor Technology Inc.

    K-Tube Technologies

    Carclo Technical Plastics

    Eurofins Medical Device Testing
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Understanding Key Processes for Mixing APIs with Silicone

    How to Minimize Color Variations in Your Medical Device

    Don’t Touch: Gesture Tech Is Reshaping How We Interact with Devices

    Revenue-Based Financing: A New Form of Growth Capital

    Pre-Filled Safety Syringes and the Self-Administration Trend
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Glenbrook Technologies Inc.

    NN Life Sciences/Paragon Medical

    Aran Biomedical

    Marox Corporation

    S-Y-M Products Company
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Impact of Change on Regulatory Compliance

    The Impact of Change on Regulatory Compliance
    Related CONTENT
    • Maintaining Compliance in the Digital Age
    • Professional Development for the Quality/Regulatory Professional
    • The Regulatory Outlook for 2019
    • Merit Medical Acquires Primary Assets of Vascular Insights
    James A. Dunning, Principal, QPC Services LLC01.30.19
    It’s that time of year again.

    Time for a calendar change. Out with the old and in with the new. Time for another 12-month journey into the unknown.

    It’s also time for new beginnings—a period that can be simultaneously fun, exhilarating, scary, and nerve-wracking. In the medtech world, these fresh starts can be particularly stressful, as they often lead to a new round of regulatory inspections. These reviews can vex even the most established companies due to the changing nature of the industry. Change can stress regulatory compliance, and consequently, the state of inspection readiness. 

    Here are some examples of changes that can stress the state of regulatory compliance and inspectional readiness (listed in no particular order): 
    • Mergers
    • Acquisitions
    • New products
    • New processes
    • New markets
    • Changes in regulatory requirements
    • Loss, addition, and/or movement of key personnel
    • New competition
    • Business performance (financial)
    • New control/support systems
    Let’s take a look at each of these pressure points in detail.

    Mergers can be trouble for regulatory compliance because they almost always include changes in management personnel, organizational structure, product category/volume, product transfers, quality management system (QMS) policy/procedural changes, and increased workloads in training, change control activities, and qualification/validation. Mergers also tend to change the vision, mission, and beliefs of the operating model used by the combined companies. These changes can make stakeholders more anxious about their futures with the new entity, especially when the merger leads to personnel cuts. Bottom line: All these challenges can create a perfect (stress) storm for regulatory compliance.

    Acquisitions are much like mergers but usually are not quite as involved because one company is being “added” to an existing QMS. Nevertheless, acquisitions are easier in theory than in practice; like mergers, they can raise the stress level in organizations (and stakeholders) due to the uncertainty they create about the company’s future direction and mission. Management, however, must remain focused and handle all the significant changes occurring to the purchasing firm.

    Most medtech executives would agree that new products are a positive facet of business. But new products can certainly stress regulatory compliance professionals because they often involve new manufacturing processes or require the creation of new, previously unfamiliar product categories that have unique mandates. Moreover, new innovations can feature new technologies that must be addressed within the QMS. New products also increase workloads on training, change control, and other support systems, adding to regulatory compliance executives’ anxiety levels. Adding to the stress is the potential modification to existing facilities or the acquisition and/or building of new facilities to manufacture the new product(s). Another trouble spot is the additional personnel that may be required to develop new products, and the fact that some of these new hires may need to be skilled or experts in areas with which the organization is unfamiliar. The cost of new products can also stress an organization financially, adding to the sense of urgency felt within organizations. A sense of urgency is a good thing, but it can be a headache for regulatory compliance.

    New markets often come with new regulatory agencies and mandates that might be unknown to the organization. Thus, the QMS may need to be significantly revised to comply with the new standards. Although industry harmonization is endorsed by many global supervisory bodies, exposure to new regulatory agencies and requirements can nevertheless put a strain on regulatory compliance.

    Regulatory changes are an obvious hassle for regulatory compliance. It seems as if these changes are constantly occurring, thanks in part to the innovation taking place within the medtech industry. Such rapid technological advancements and the general evolution of regulatory requirements can make it difficult for companies to stay abreast of the latest mandates.

    Loss, addition, and/or movement of key personnel is another discernable source of regulatory compliance stress. Everyone is replaceable; yet, when essential workers are furloughed or fired, it can leave an empty hole in an organization. There usually are people within companies that contribute to the QMS and associated level of regulatory compliance in ways that are not always captured in job descriptions or QMS tools. The loss of these workers can have a greater-than-expected effect on the organization, and the surprise impact of the loss can strain regulatory compliance efforts. Conversely, adding key personnel can sometimes trigger anxiety in regulatory compliance professionals, especially when the new personnel are placed in decision-making positions within the company. Typically, this does not happen intentionally, and the decrease in regulatory compliance status may take some time to identify. Even when identified, though, the cause of the decrease may not be linked to additional key personnel. Movement of personnel can affect the regulatory compliance status just as much as the loss or addition of key workers. Moving a new employee into a key new role can add unanticipated stress to the QMS and result in a lower level of regulatory compliance status.

    New competition can stress regulatory compliance as well. Here’s why: The player handling product categories typically has integrated newer technology and/or lower costs into a medtech firm’s invention(s).  Often, these players focus on delivering unmet stakeholder needs to the market. In response, established companies may push themselves to develop products faster; improve their innovations, processes, and customer service; and lower manufacturing costs to maintain market share.  Such improvements are positive, but the changes required to achieve them can burden the QMS and subsequently the state of regulatory compliance as well.

    In most regions of the world, success is generally measured by business performance (i.e., financial performance). When business performance decreases or does not meet expectations, the organization drives changes (or attempts to drive changes) to improve its overall functioning. In these cases, regulatory compliance can unintentionally be overlooked, or at the very least, be undervalued as an overall success factor.

    New control or support systems such as an Enterprise Resource Planning system can certainly improve operational performance and enhance the QMS; integration of these systems, however, can have a negative impact on the state of regulatory compliance. Often the transition takes longer than expected, prompting companies to implement temporary stopgap measures to avoid noncompliance. Yet sometimes these temporary measures are extended so frequently that they begin to break down, and consequently, reduce the level of regulatory compliance.

    The changes I’ve discussed are inevitable. But they’re not insurmountable obstacles, and they don’t necessarily have to become stressors to the regulatory compliance system. To keep anxiety levels low, regulatory professionals should consider: 
    • Being an active part of the change process. Regulatory professionals are often seen as resistant to change (frequently without due cause), but hard work, focus, and collaboration can reduce this perception and thereby enhance their influence. The age-old axiom “if you are not part of the solution, you are part of the problem” applies here. Work hard to be seen as part of the solution, and help the organization focus on regulatory compliance throughout the change process.
    • Listen. Regulatory professionals are most effective when they listen to others in their organizations. It is tempting to speak up too quickly, but take a breath and listen. This is the best way to get other professionals in the organization to listen to the regulatory expert both as an individual and as part of a group. This mutual level of listening within the organization will result in a better understanding of the stressors presented by the change(s) the organization is experiencing.
    • Speak up when necessary. Most medtech companies work hard to maintain compliance, but regulatory professionals have a responsibility to identify situations where amenability could be adversely affected. Don’t hesitate to speak up in these situations.
    Change is inevitable, as is the resulting stress to current systems. The regulatory professional plays a key role in helping to prevent or at least reduce the effect of change on regulatory compliance.


    James A. “Jim” Dunning’s consulting career began in 2001. He has provided quality and regulatory consulting services for various companies ranging from Fortune 500 medical device firms to startups. Dunning’s passion, however, lies with startups and small companies, especially those in regulatory distress. He has amassed significant experience in preparing 510(k) applications, developing complete Quality Management Systems, providing Quality System Training, and advising on quality, business, and leadership issues. Dunning is a senior member of the American Society for Quality (ASQ) and a member of the Regulatory Affairs Professional Society (RAPS). He can be reached at jdunning@qpcservices.com. 
    Related Searches
    • standards
    • manufacture
    • evolution
    • medical
    Suggested For You
    Merit Medical Acquires Primary Assets of Vascular Insights Merit Medical Acquires Primary Assets of Vascular Insights
    The Regulatory Outlook for 2019 The Regulatory Outlook for 2019
    Professional Development for the Quality/Regulatory Professional Professional Development for the Quality/Regulatory Professional
    Maintaining Compliance in the Digital Age Maintaining Compliance in the Digital Age

    Related Columns

    • Diagnostics
      From Genome Sequencing to the World’s First Portable MRI

      From Genome Sequencing to the World’s First Portable MRI

      Dr. Jonathan Rothberg has risen about as high as a scientist can, save for the Nobel Prize.
      Sam Brusco, Associate Editor 11.04.19

    • Digital Health
      An Update on Digital Health

      An Update on Digital Health

      Sure, most are startups—but not all. There were some brilliant ideas presented at The MedTech Conference (AdvaMed’s annual meeting) on Sept. 23-25 in Boston and the Connected Health Conference, also in Boston, put on by Partners Health…
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 11.04.19


    • Five Steps for Succeeding Globally in Medtech

      Five Steps for Succeeding Globally in Medtech

      World views can differ considerably, so it is important to understand, appreciate, and respect cultural realities and differences.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.19

    • Software & IT
      Unlocking Market Doors with Real-World Evidence

      Unlocking Market Doors with Real-World Evidence

      Real-world evidence is becoming increasingly important for manufacturers to demonstrate value beyond efficacy and safety standards.
      Seth Goldenberg, Ph.D., Vice President, Vault Medical Device & Diagnostics, Veeva Systems 11.04.19

    • Contract Manufacturing
      Sales Tips for Contract Manufacturers of Finished Devices

      Sales Tips for Contract Manufacturers of Finished Devices

      Evolving trends in the supply chain may require companies to consider a strategy of selling devices of their own design.
      Tony Freeman, President, A.S. Freeman Advisors LLC 11.04.19


    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 11.04.19

    • R&D & Design
      Perfecting Drug Delivery Device Design

      Perfecting Drug Delivery Device Design

      Unlike medical products that just need to work, drug delivery devices must also consider intuitiveness, usability, and how it makes the user feel when operated.
      Bryce G. Rutter, Ph.D., Founder & CEO, Metaphase Design Group Inc. 11.04.19

    • Diagnostics
      Elizabeth Holmes: The Making of a Pop Culture Icon

      Elizabeth Holmes: The Making of a Pop Culture Icon

      Despite keeping a relatively low profile this year (not by choice), Elizabeth Holmes’ celebrity status has continued to grow.
      Michael Barbella, Managing Editor 10.08.19


    • A Look at Physician/Surgeon Salary and Employment Statistics

      A Look at Physician/Surgeon Salary and Employment Statistics

      No more call for physicians? Not really, but schedule predictability is in for physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 10.08.19

    • Bridging Generation Gaps to Build Better Teams and Business

      Bridging Generation Gaps to Build Better Teams and Business

      I’ve learned the hard way that building teams of motivated, productive employees is equal parts science and art.
      Dawn A. Lissy, President & Founder, Empirical 10.08.19

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19

    • Testing
      Preparing for MDR: Test In-House or Outsource?

      Preparing for MDR: Test In-House or Outsource?

      As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing 10.08.19

    • Think Chinese Tariffs Are the Only Industry Job Killers? Think Again

      Think Chinese Tariffs Are the Only Industry Job Killers? Think Again

      One of the latest concerns—arising from an old issue—is the medical device tax, which could return next year without legislative intervention before then.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 10.08.19

    • Contract Manufacturing | Software & IT
      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Industry 4.0 represents the dawn of the digital transformation that began with the third revolution, connecting the physical and natural worlds.
      Scott Reedy, Senior Director of Marketing, Arena Solutions 10.08.19


    Breaking News
    • FDA OKs Roche's Nasal Swab MRSA Test
    • Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    • Eye Test for Parkinson's Gains Breakthrough Designation
    • Biomerics Forms New Business Unit
    • J&J's New Monofocal IOL for Cataract Patients with Astigmatism
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    Cristo Rey High School Educator Named 2019 Axalta All-Pro Teacher of the Year
    Michelman Makes United Way of Greater Cincinnati’s List of Top 25 Corporate Campaigns
    BCF: Coatings Industry Reports Record Improvement in Waste, Recycling, Accident Rates
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Roche's Nasal Swab MRSA Test
    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    Eye Test for Parkinson's Gains Breakthrough Designation
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Awarded $1M BMGF Grant
    Vivera Pharma, Parexel Ink Clinical Services Agreement
    MedPharm Triples Capacity at RTP Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    WWP Wins Three NJPEC Awards
    Cat-Themed Beauty Collection to Launch in Japan
    Pantone Names Classic Blue the 2020 Color of the Year
    Happi

    Latest Breaking News From Happi

    Lip Lab Opening in Brooklyn
    Raining Rose Expands Exec Team
    Scott’s Sells Personal Care Production Site
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Haney, HP Developing Sustainable Fashion Packaging for Heron Preston
    Addipel Moves to New HQ, Expands Production Facility
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    HP teams with Haney for sustainable packaging
    Tags & Labels Printing adds Heidelberg’s Versafire EP
    Austrian converter installs first Nilpeter press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Thrace to Relocate U.S. Capacity
    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Appoints New Spine Business Leader
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    IDTechEx Show! Announces Graphene Award Winner
    OE-A Continues to Bring Future of Printed Electronics to CES 2020
    Avancis, Smit Thermal, HZB, CNRS, Solliace Team for Higher Efficiencies in CIGS

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.